Clinical Trial Supplies Market worth $5.7 billion by 2027 - Exclusive Report by MarketsandMarkets™

CHICAGO, Oct. 24, 2022 /PRNewswire/ -- Clinical Trial Supplies Market is projected to reach USD 5.7 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 9.7% during the forecast period of 2022 to 2027 according to a new report by MarketsandMarkets™. Factors such as growing R&D expenditure in biopharmaceutical and pharmaceutical companies and the growing number of clinical trials conducted globally. However, during the forecast period, the growing cost of clinical trials and drug development is expected to restrain the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172240059

Browse in-depth TOC on "Clinical Trial Supplies Market"

246 - Tables
39 - Figures
264 - Pages

The logistics and distribution segment accounted for the largest share of the services segment in the clinical trial supplies market in 2021.

On the basis of the service, the clinical trial supplies market is segmented into manufacturing; packaging, labeling, and blinding; comparator sourcing; logistics & distribution; storage & retention; and other services. In 2021, Logistics & distribution services accounted for a share in the market. During the forecast period, this segment is estimated to grow at the highest CAGR. Logistics & distribution and storage & retention are seen to be the leading segments with respect to the growth rate during the forecast period as a result of growing decentralization of clinical trials.

The oncology segment accounted for the largest share of the therapeutic area segment in the clinical trial supplies market in 2021

On the basis of therapeutic area, the clinical trial supplies market is divided into oncology, CNS & mental disorders, cardiovascular diseases, digestive disorders, infectious diseases, metabolic disorders, immunology, blood disorders, and other therapeutic areas (respiratory disorders, dermatological disorders, rare diseases, ENT diseases, Nephrology). In 2021, Oncology accounted for the largest segment in this market. Factors such as increasing number of research studies on cancer therapeutics and the growing companies focusing on cancer drugs into the market. During the forecast period, the oncology segment is projected to grow at the highest CAGR.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=172240059

The Asia Pacific region is the fastest-growing region of the clinical trial supplies market in 2021.

On the basis of region, the clinical trial supplies market is broadly segmented into North America, Europe, the Asia Pacific, and the Rest of the World. During the forecast period, the Asia Pacific market is projected to register the highest growth. Factors such as emerging number of players, regulatory framework, huge population base and cost-effectiveness in Asia Pacific regions is driving the growth in the market. This is attracting the attention of a majority of pharmaceutical, biopharmaceutical, and biotechnology giants to consider conducting their clinical trials in Asia Pacific countries.

Key players in the Clinical trial supplies market include Thermo Fisher Scientific (US), Marken (US), Catalent, Inc. (US), Eurofins Scientific (France), and PRA Health Sciences (US).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=172240059

Browse Adjacent Market: Pharmaceuticals Market Research Reports & Consulting

Related Reports:

CRO Services Market - Global Forecasts to 2027

Clinical Trial Imaging Market - Global Forecasts to 2026

eClinical Solutions Market - Global Forecasts to 2026

Clinical Trial Management System Market - Global Forecasts to 2025

ePrescribing Market - Global Forecasts to 2025

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/clinical-trial-supplies-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/clinical-trial-supplies.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

SOURCE MarketsandMarkets